Boston Scientific's Ranger Drug-Coated Balloon (DCB) Catheter
Drug-Coated Balloons for Coronary Artery Disease: Third Report of the International DCB Consensus Group | JACC: Cardiovascular Interventions
Positive results for Boston Scientific Ranger paclitaxel-coated PTA balloon catheter - Vascular News
First Hospital in the State to Successfully Deploy the Ranger Drug Coated Balloon™ | Missouri Delta Medical Center
Boston Scientific to sell Bard's Lutonix balloon - MassDevice
Boston Scientific - Wikipedia
Boston Scientific to Distribute Bard's Lutonix Drug-eluting Balloon | DAIC
Positive Data for the Ranger Drug-coated Balloon and Eluvia Vascular Stent | DAIC
BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR FOURTH QUARTER AND FULL YEAR 2022
Boston Scientific Announces Positive Late-Breaking Clinical Trial Data for the Ranger™ Drug-Coated Balloon – Medical Device News Magazine
Ranger Drug-Coated Balloon Receives FDA Approval Reports Boston Scientific – Medical Device News Magazine
AGENT IDE trial to evaluate DCB-use in patients with coronary in-stent restenosis - Cardiovascular News
Agentᵀᴹ Drug Coated Eluting Balloon - Boston Scientific
Agentᵀᴹ Drug Coated Eluting Balloon - Boston Scientific
Catheters: Balloon - Boston Scientific
Boston Scientific 3917108104 Mustang PTA Balloon Dilation Catheter
Boston Scientific H7493926730400 NC Emerge Monorail™ PTCA Dilatation Catheter
Drug-Coated Balloons for Coronary Artery Disease: Third Report of the International DCB Consensus Group - ScienceDirect
Peripheral Artery Disease Treatment: Paclitaxel & Sirolimus | VER Journal
iVascular Launches Essential Pro Coronary Drug-coated Balloon | DAIC
Boston Scientific Receives CE Mark For Agent Drug-Coated Balloon | DAIC
DRUG TRANSFER
Drug Eluting Balloon Market Size, Growth, Trends and Forecast to 2028 | Medtronic, Becton, Boston Scientific Corporation | Medgadget
Drug-Eluting Technology – Vascular Stent – Boston Scientific - Boston Scientific
Ranger™ - Boston Scientific
